China’s mRNA Tumor Vaccine for Epstein-Barr Virus Approved for Clinical Trials
China approves an mRNA vaccine targeting Epstein-Barr virus positive tumors for clinical trials, marking a significant advancement in cancer immunotherapy.
News & Insights Across Asia
China approves an mRNA vaccine targeting Epstein-Barr virus positive tumors for clinical trials, marking a significant advancement in cancer immunotherapy.